Metformin as an Anticancer Agent

被引：208
作者：
Vancura, Ales [1 ]
Bu, Pengli [1 ]
Bhagwat, Madhura [1 ]
Zeng, Joey [1 ]
Vancurova, Ivana [1 ]
机构：
[1] St Johns Univ, Dept Biol Sci, Queens, NY 11439 USA
来源：
TRENDS IN PHARMACOLOGICAL SCIENCES | 2018年 / 39卷 / 10期
关键词：
ACTIVATED PROTEIN-KINASE; AMINO-ACID LEVELS; BREAST-CANCER; RAG GTPASES; PROSTATE-CANCER; OPPORTUNITY NEOADJUVANT; HEPATIC GLUCONEOGENESIS; CELL-PROLIFERATION; GLUCOSE-PRODUCTION; CARBON METABOLISM;
D O I：
10.1016/j.tips.2018.07.006
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Metformin has been a frontline therapy for type 2 diabetes (T2D) for many years. Its effectiveness in T2D treatment is mostly attributed to its suppression of hepatic gluconeogenesis; however, the mechanistic aspects of metformin action remain elusive. In addition to its glucose-lowering effect, metformin possesses other pleiotropic health-promoting effects that include reduced cancer risk and tumorigenesis. Metformin inhibits the electron transport chain (ETC) and ATP synthesis; however, recent data reveal that metformin regulates AMP-activated protein kinase (AMPK) and the mechanistic target of rapamycin complex 1 (mTORC1) by multiple, mutually nonexclusive mechanisms that do not necessarily depend on the inhibition of ETC and the cellular ATP level. In this review, we discuss recent advances in elucidating the molecular mechanisms that are relevant for metformin use in cancer treatment.
引用
收藏
页码：867 / 878
页数：12
相关论文
共 103 条
[1]   A Tumor Suppressor Complex with GAP Activity for the Rag GTPases That Signal Amino Acid Sufficiency to mTORC1 [J].
Bar-Peled, Liron ;
Chantranupong, Lynne ;
Cherniack, Andrew D. ;
Chen, Walter W. ;
Ottina, Kathleen A. ;
Grabiner, Brian C. ;
Spear, Eric D. ;
Carter, Scott L. ;
Meyerson, Matthew ;
Sabatini, David M. .
SCIENCE, 2013, 340 (6136) :1100-1106
[2]   Ragulator Is a GEF for the Rag GTPases that Signal Amino Acid Levels tomTORC1 [J].
Bar-Peled, Liron ;
Schweitzer, Lawrence D. ;
Zoncu, Roberto ;
Sabatini, David M. .
CELL, 2012, 150 (06) :1196-1208
[3]   Metformin as a Tool to Target Aging [J].
Barzilai, Nir ;
Crandall, Jill P. ;
Kritchevsky, Stephen B. ;
Espeland, Mark A. .
CELL METABOLISM, 2016, 23 (06) :1060-1065
[4]   Control of Gluconeogenesis by Metformin: Does Redox Trump Energy Charge? [J].
Baur, Joseph A. ;
Birnbaum, Morris J. .
CELL METABOLISM, 2014, 20 (02) :197-199
[5]   mTORC1 signaling and the metabolic control of cell growth [J].
Ben-Sahra, Issam ;
Manning, Brendan D. .
CURRENT OPINION IN CELL BIOLOGY, 2017, 45 :72-82
[6]   An Essential Role of the Mitochondrial Electron Transport Chain in Cell Proliferation Is to Enable Aspartate Synthesis [J].
Birsoy, Kivanc ;
Wang, Tim ;
Chen, Walter W. ;
Freinkman, Elizaveta ;
Abu-Remaileh, Monther ;
Sabatini, David M. .
CELL, 2015, 162 (03) :540-551
[7]   From rapalogs to anti-aging formula [J].
Blagosklonny, Mikhail V. .
ONCOTARGET, 2017, 8 (22) :35492-35507
[8]   AMPK Re-Activation Suppresses Hepatic Steatosis but its Downregulation Does Not Promote Fatty Liver Development [J].
Boudaba, Nadia ;
Marion, Allison ;
Huet, Camille ;
Pierre, Remi ;
Viollet, Benoit ;
Foretz, Marc .
EBIOMEDICINE, 2018, 28 :194-209
[9]   Mitochondrial Targeting of Metformin Enhances Its Activity against Pancreatic Cancer [J].
Boukalova, Stepana ;
Stursa, Jan ;
Werner, Lukas ;
Ezrova, Zuzana ;
Cerny, Jiri ;
Bezawork-Geleta, Ayenachew ;
Pecinova, Alena ;
Dong, Lanfeng ;
Drahota, Zdenek ;
Neuzil, Jiri .
MOLECULAR CANCER THERAPEUTICS, 2016, 15 (12) :2875-2886
[10]   Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria [J].
Bridges, Hannah R. ;
Jones, Andrew J. Y. ;
Pollak, Michael N. ;
Hirst, Judy .
BIOCHEMICAL JOURNAL, 2014, 462 :475-487
12345678910